ブックタイトル血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

概要

血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

112. Bhutta A, Gilliam C, Honeycutt M, et al. Reduction of bloodstream infections associated with catheters inpaediatric intensive care unit: stepwise approach. BMJ 2007; 334:362?5.113. Chelliah A, Heydon KH, Zaoutis TE, et al. Observational trial of antibiotic-coated central venous catheters incritically ill pediatric patients. Pediatr Infect Dis J 2007; 26:816?20.114. van de Wetering MD, van Woensel JBM. Prophylactic antibiotics for preventing early central venouscatheter Gram positive infections in oncology patients. Cochrane Database of Systematic Reviews 2007;Issue 1. Art. No.: CD003295. DOI: 10.1002/ 14651858.CD003295.pub2.115. Maki DG, Band JD. A comparative study of polyantibiotic and iodophorointments in prevention of vascularcatheter-related infection. Am J Med 1981; 70:739?44.116. Fukunaga A, Naritaka H, Fukaya R, Tabuse M, Nakamura T. Povidone-iodine ointment and gauze dressingsassociated with reduced catheter-related infection in seriously ill neurosurgical patients. Infect Control HospEpidemiol 2004; 25:696?8.117. Johnson DW, MacGinley R, Kay TD, et al. A randomized controlled trial of topical exit site mupirocinapplication in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 2002;17:1802?7.118. Fong IW. Prevention of haemodialysis and peritoneal dialysis catheter related infection by topical povidoneiodine.Postgrad Med J 1993; 69(Suppl 3):S15?7.119. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheterinfections by topical povidone-iodine. Kidney Int 1991; 40:934?8.120. Schwartz C, Henrickson KJ, Roghmann K, Powell K. Prevention of bacteremia attributed to luminalcolonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol1990; 8:1591?7.121. Rackoff WR, Weiman M, Jakobowski D, et al. A randomized, controlled trial of the efficacy of a heparin andvancomycin solution in preventing central venous catheter infections in children. J Pediatr 1995; 127:147?51.122. Carratala J, Niubo J, Fernandez-Sevilla A, et al. Randomized, double-blind trial of an antibiotic-locktechnique for prevention of gram-positive central venous catheter-related infection in neutropenic patientswith cancer. Antimicrob Agents Chemother 1999; 43:2200?4.123. Jurewitsch B, Lee T, Park J, Jeejeebhoy K. Taurolidine 2% as an antimicrobial lock solution for preventionof recurrent catheter-related bloodstream infections. J Parenter Enteral Nutr 1998; 22:242?4.124. Henrickson KJ, Axtell RA, Hoover SM, et al. Prevention of central venous catheter-related infections andthrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/ heparin flushsolution: a randomized, multicenter, double-blind trial. J Clin Oncol 2000; 18:1269?78.125. Garland JS, Alex CP, Henrickson KJ, McAuliffe TL, Maki DG. A vancomycin-heparin lock solution forprevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted centralvenous catheters: a prospective, randomized trial. Pediatrics 2005; 116:e198?205.126. Daghistani D, Horn M, Rodriguez Z, Schoenike S, Toledano S. Prevention of indwelling central venouscatheter sepsis. Med Pediatr Oncol 1996; 26:405?8.127. Barriga FJ, Varas M, Potin M, et al. Efficacy of a vancomycin solution to prevent bacteremia associated withan indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Med PediatrOncol 1997; 28:196?200.128. Dogra GK, Herson H, Hutchison B, et al. Prevention of tunneled hemodialysis catheter-related infectionsusing catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am SocNephrol 2002; 13:2133?9.55